1. Yu Lu, Di Zhu, Quynh Le, Yuji Wang* and Wei Wang*.An NMR Study on Hydration and Molecular Interaction of Phytantriol-Based Liquid Crystals.Pharmaceutics.2022.14.2312.SCI |
2. Yu Lu, Di Zhu, Quynh Le, Yuji Wang* and Wei Wang*.Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy.Nanoscale.2022.14.16339-16375.SCI |
3. Di Zhu, Yu Lu, Yanming Wang* and Yuji Wang*.PAD4 and Its Inhibitors in Cancer Progression and Prognosis.Pharmaceutics.2022.14.2414.SCI |
4. Yu Zhao, Ran Lu, Xin Wang, Xiaochen Huai, Caiyun Wang, Yuji Wang*, SApplied Nanoscienceu Chen.Visible light-induced antibacterial and osteogenic cell proliferation properties of hydrogenated TiO2 nanotubes/Ti foil composite.Nanotechnology.2021.32.195101.SCI |
5. Peng Wang, Lin Gui, Yuji Wang,* Sheng Wang*.In vitro evaluation of a pectin-RGDS-OC8H17-paclitaxel nano-particle coated balloon.Applied Nanoscience.2021.11.1339-47.SCI |
6. Yu Lu, Di Zhu, Lin Gui, Yuanming Li, Wenjing Wang, Jiawang Liu Yuji Wang*.A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis by the PARP/ATM pathway.Journal of Nanobiotechnology.2021.19(1).115.SCI |
7. Ming Wei, Xia Wang, Yanting Song, Di Zhu, Dan Qi, Shiyu Jiao, Guomin Xie, Ye Liu, Baoqi Yu, Jie Du, Yuji Wang*, Aijuan Qu*.Inhibition of peptidyl arginine deiminase 4-dependent neutrophil extracellular traps formation reduces angiotensin II-induced abdominal aortic aneurysms rupture in mice.Front Cardiovasc Med.2021.8.676612.SCI |
8. Yu Lu, Zidong Peng, Di Zhu, Yijiang Jia, Ayijiang Taladaohan, Yuanming Li, Jiawang Liu, Yanming Wang, Yuji Wang*.RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety.International Journal of Nanomedicine.2021.16.5565-5580.SCI |
9. Di Zhu#, Yu Lu#, Lin Gui, Wenjing Wang, Xi Hu, Su Chen, Yanming Wang, Yuji Wang*.Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment.Acta Pharmaceutica Sinica B.2021. .https://doi.org/10.1016/j.apsb.2021.11.006.SCI |
10. Peng Wang, Lin Gui, Yuji Wang,* Sheng Wang*.In vitro evaluation of a pectin-RGDS-OC8H17-paclitaxel nano-particle coated balloon.Applied Nanoscience.2021.11.1339-1347.SCI |
11. Yu Lu, Di Zhu, Lin Gui, Yuanming Li, Wenjing Wang, Jiawang Liu and Yuji Wang*.A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis by the PARP/ATM pathway.Journal of Nanobiotechnology.2021.doi: 10.21203/rs.3.rs-36952/v1.SCI |
12. Xueyuan Chen, Yi Zheng, Songlin Song,Ying Liu, Yi Wang,Yong Huang,Xiaoyi Zhang, Meng Zhang, Ming Zhao, Yuji Wang*, Li Li*.Design and Synthesis of Biotinylated Bivalent Carboline Derivatives as Potent Antitumor Agents. J. Org. Chem.2020.85(18).11618–11625.SCI |
13. Songlin Song, Lin Gui, Qiqi Feng, Ayijiang Taledaohan, Yuanming Li, Wei Wang, Yanming Wang and Yuji Wang*.TAT- modified gold nanoparticles enhance the anti-tumor activity of PAD4 inhibitors.International Journal of Nanomedicine.2020.15.6659-6671.SCI |
14. Lu R, Wang C, Wang X, Wang Y, Wang N, Chou J, Li T, Zhang Z, Ling Y, Chen S..Effects of hydrogenated TiO2 nanotube arrays on protein adsorption and compatibility with osteoblast-like cells..Int J Nanomedicine. 2018 Apr 4;13:..2018.13.2037-2049.SCI |
15. Xu X, Wang Y, Wu J, Hu X, Zhu H, Zhang X, Wang Y, Gui L, Zhao M, Peng S..ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo..Int J Nanomedicine. 2017 Jun 13;12:.2017.12.4415-4431.SCI |
16. Wang Y, Xu X, Song C, Wu J, Hu X, Zhu H, Zhang X, Wang Y, Gui L, Zhao M, Peng S..ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo..Oncotarget.2017.8(38).63881-63889.SCI |
17. Liu J, Pham PT, Skripnikova EV, Zheng S, Lovings LJ, Yuji Wang, Goyal N, Bellow SM, Mensah LM, Chatters AJ, Bratton MR, Wiese TE, Zhao M, Wang G, Foroozesh M..A Ligand-Based Drug Design, Discovery of 4-Trifluoromethyl-7,8-Pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2..J Med Chem.2015.58(16).6481-6493.SCI |
18. Yuji Wang, Jingcheng Tang, Haimei Zhu, Xueyun Jiang, Jiawang Liu, Wenyun Xu, Haiping Ma, Qiqi Feng, Jianhui Wu, Ming Zhao, Shiqi Peng..Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis.International Journal of Nanomedicine.2015.10.6905-6918.SCI |
19. Yuji Wang.Novel nano-materials, RGD-tetrapeptide-modified 17b-amino-11a-hydroxyandrost-1,4-diene-3-one: synthesis, self-assembly based nano-images and in vivo anti-osteoporosis evaluation.. Journal of Materials Chemistry.2012.22(11).4652-4659..SCI |
20. Yuji Wang.Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-Pentahydroxylhex1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction..Metallomics.2012.4(5).441-447..SCI |
21. Huiliang Zhang#, Yuji Wang#. Synthesis and In Vivo Lead Detoxification Evaluation of Poly-α,β-DL-aspartyl-L-methionine..Chemical Research in Toxicology.2012.25(2).471-477..SCI |
22. Guifeng Kang#, Yuji Wang#.Development of three-component conjugates: To get nano-globes with porous surface, high in vivo anti-osteoporosis activity and minimal side effects.. Journal of Materials Chemistry.2012.22(40).21740-21748.SCI |
23. Yuji Wang.HPLC-MS aided PC12 cell systems: to quantitatively monitor the conversion of nitronyl nitroxide in biological systems with and without NO..Molecular BioSystems.2011.7(5).1678-1683..SCI |
24. Yuji Wang.Development of highly effective three-component cytoprotective adjuncts for cisplatin cancer treatment: synthesis and in vivo evaluation in S180-bearing mice..Metallomics.2011.3(11).1212-1217..SCI |
25. Yuji Wang.A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin..Molecular BioSystems.2011.7(12).3245-3252..SCI |